Literature DB >> 3099616

Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea.

M Berthon-Jones, C E Sullivan.   

Abstract

Nineteen subjects with the obstructive sleep apnea syndrome (10 with daytime arterial CO2 tension 44 mm Hg or higher) were treated with long-term nocturnal continuous positive airway pressure. The ventilatory response to CO2 (Read's method) was measured in triplicate prior to treatment and after 1, 2, 3, 7, and 14 or more nights of therapy. Seven subjects were tested on at least 4 occasions. For each test, slope of the response line and position of the response line (ventilation at a PCO2 of 60 mm Hg) were calculated. The subjects with initial high daytime CO2 showed no change in slope of response with treatment but showed a progressive increase in ventilation at any given degree of PCO2. Ventilation at a PCO2 of 60 mm Hg increased from a mean of 20.0 +/- 1.3 SEM L/min by 8.0 +/- 2.5 SEM L/min after 2 nights of therapy (p less than 0.05, two-way analysis of variance), and by 16.2 +/- 1.9 L/min after 2 wk or more (p less than 0.01). On average, there was no significant change in either slope or position of response in the subjects with initially normal daytime PCO2. We conclude that airway obstruction in sleep (in obstructive sleep apnea syndrome) leads in some subjects to respiratory failure in the daytime, with a left shift in the ventilatory response to CO2, and that this changes is usually reversible during the next several days.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3099616     DOI: 10.1164/arrd.1987.135.1.144

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  23 in total

Review 1.  Rationale for the use of non-invasive ventilation in chronic ventilatory failure.

Authors:  P M Turkington; M W Elliott
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

2.  CPAP titration failure is not equivalent to long-term CPAP treatment failure in patients with obesity hypoventilation syndrome: a case series.

Authors:  Alejandra C Lastra; Juan F Masa; Babak Mokhlesi
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

3.  Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention.

Authors:  Xiaofan Wu; Shuzheng Lv; Xiaohong Yu; Linyin Yao; Babak Mokhlesi; Yongxiang Wei
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

4.  Obstructive sleep apnea: therapeutic compliance.

Authors:  J P Baker; V Rose; C Ware
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

5.  Hypercapnia in overlap syndrome: possible determinant factors.

Authors:  Onofrio Resta; Maria Pia Foschino Barbaro; Caterina Brindicci; Maria Cristina Nocerino; Gennaro Caratozzolo; Monica Carbonara
Journal:  Sleep Breath       Date:  2002-03       Impact factor: 2.816

Review 6.  Obstructive sleep apnoea.

Authors:  S G McNamara; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

7.  Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome.

Authors:  R Jokic; T Zintel; G Sridhar; C G Gallagher; M F Fitzpatrick
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

8.  Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea/hypopnea syndrome.

Authors:  Laura R Young; Zachary H Taxin; Robert G Norman; Joyce A Walsleben; David M Rapoport; Indu Ayappa
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

9.  Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired?

Authors:  Andrea Loewen; Michele Ostrowski; John Laprairie; Raj Atkar; January Gnitecki; Patrick Hanly; Magdy Younes
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

Review 10.  Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.

Authors:  Carlos Zamarrón; Vanesa García Paz; Emilio Morete; Felix del Campo Matías
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.